Vaxtex Historical Cash Flow
| VCL Stock | 0.94 0.02 2.17% |
Analysis of Vaxtex Cotfab cash flow over time is an excellent tool to project Vaxtex Cotfab Limited future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change To Inventory of 13.6 M or Change In Working Capital of 31.1 M as it is a great indicator of Vaxtex Cotfab ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Vaxtex Cotfab Limited latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vaxtex Cotfab Limited is a good buy for the upcoming year.
Vaxtex |
About Vaxtex Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Vaxtex balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Vaxtex's non-liquid assets can be easily converted into cash.
Vaxtex Cotfab Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Vaxtex Cotfab's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Vaxtex Cotfab Limited current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxtex Cotfab Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At present, Vaxtex Cotfab's Change In Working Capital is projected to decrease significantly based on the last few years of reporting. The current year's Begin Period Cash Flow is expected to grow to about 1.6 M, whereas Free Cash Flow is projected to grow to (112.3 M).
Vaxtex Cotfab cash flow statement Correlations
Click cells to compare fundamentals
Vaxtex Cotfab Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vaxtex Cotfab cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 24.0M | (37.0M) | 40.7M | 11.3M | 13.0M | 13.6M | |
| Change In Cash | (791.9K) | 355.0K | (564K) | (706K) | (635.4K) | (603.6K) | |
| Free Cash Flow | (6.9M) | 18.2M | (118.8M) | (131.4M) | (118.2M) | (112.3M) | |
| Change In Working Capital | (5.0M) | (8.9M) | (116.8M) | 33.0M | 29.7M | 31.1M | |
| Begin Period Cash Flow | 1.9M | 1.1M | 1.5M | 930K | 837K | 1.6M | |
| Other Cashflows From Financing Activities | (10.9M) | (3.8M) | 113.6M | (658K) | (756.7K) | (718.9K) | |
| Other Non Cash Items | 10.2M | 7.6M | (16.1M) | (77.5M) | (69.7M) | (66.3M) | |
| Capital Expenditures | 16.2M | 3.6M | 231K | 141.4M | 162.7M | 170.8M | |
| Total Cash From Operating Activities | 9.3M | 21.7M | (118.6M) | (131.4M) | (118.2M) | (112.3M) | |
| Change To Account Receivables | (12.4M) | (33.6M) | (120.3M) | 25.1M | 22.6M | 23.7M | |
| Net Income | 2.6M | 20.1M | 11.6M | (88.3M) | (79.5M) | (75.5M) | |
| Total Cash From Financing Activities | (34.1M) | (10.7M) | 105.1M | 162.4M | 186.8M | 196.1M | |
| End Period Cash Flow | 1.1M | 1.5M | 930K | 224K | 201.6K | 191.5K | |
| Depreciation | 1.5M | 3.0M | 2.8M | 1.5M | 1.8M | 1.7M | |
| Other Cashflows From Investing Activities | 40.2M | 2.3M | 3.6M | (31.8M) | (28.6M) | (27.2M) | |
| Investments | 24.0M | (10.6M) | 3.4M | (31.8M) | (28.6M) | (27.2M) | |
| Change To Netincome | 10.9M | 11.1M | 7.6M | 7.7M | 8.9M | 8.8M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| S | SentinelOne | |
| CRM | Salesforce | |
| MSFT | Microsoft |
Other Information on Investing in Vaxtex Stock
The Cash Flow Statement is a financial statement that shows how changes in Vaxtex balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Vaxtex's non-liquid assets can be easily converted into cash.